Clinical-Stage Platforms
Part of Biotech - Drug Development
 TMO | Thermo Fisher Scientific, Inc. | $228.7b | $645.21 | +0.5% | 668.8K |
 IQV | IQVIA Holdings Inc. | $43.4b | $270.72 | +0.4% | 358.5K |
 A | Agilent Technologies Inc. | $42.7b | $152.71 | +1.3% | 362.4K |
 WAT | Waters Corp | $40.6b | $421.76 | +0.8% | 126.5K |
 RPRX | Royalty Pharma plc Class A Ordinary Shares | $28.4b | $58.84 | +0.7% | 578.0K |
 WST | West Pharmaceutical Services, Inc. | $24.1b | $363.26 | -0.4% | 89.3K |
 ASND | Ascendis Pharma A/S Ordinary Share | $17.5b | $243.03 | +0.6% | 298.6K |
 MEDP | Medpace Holdings, Inc. Common Stock | $16.6b | $618.92 | -0.5% | 29.6K |
 RVTY | Revvity, Inc. | $14.6b | $146.09 | +3.9% | 1.2M |
 CRL | Charles River Laboratories International, Inc. | $13.9b | $276.37 | +1.2% | 115.1K |
 HALO | Halozyme Therapeutics, Inc. | $12.4b | $106.83 | +0.5% | 308.3K |
 ICLR | Icon Plc | $12.3b | $173.68 | +0.7% | 181.1K |
 TECH | Bio-Techne Corp. | $11.4b | $72.32 | -0.1% | 772.6K |
 AVTR | Avantor, Inc. | $9.9b | $15.62 | +1.1% | 3.3M |
 KYMR | Kymera Therapeutics, Inc. Common Stock | $9.9b | $116.44 | +3.0% | 154.4K |
 RGEN | Repligen Corp | $9.6b | $175.07 | -0.0% | 147.2K |
 QGEN | QIAGEN N.V. | $9.1b | $43.05 | +0.9% | 397.5K |
 BRKR | Bruker Corporation | $9.0b | $59.16 | +6.1% | 1.3M |
 TWST | Twist Bioscience Corporation Common Stock | $8.5b | $145.29 | +5.3% | 779.2K |
 CGON | CG Oncology, Inc. Common stock | $6.6b | $73.19 | +0.7% | 125.8K |
 LGND | Ligand Pharmaceuticals Inc. | $5.7b | $274.18 | -0.6% | 80.0K |
 CELC | Celcuity Inc. Common Stock | $4.7b | $82.59 | -0.2% | 147.1K |
 RLAY | Relay Therapeutics, Inc. Common Stock | $4.2b | $18.94 | -0.3% | 278.6K |
 MANE | Veradermics, Incorporated | $4.1b | $102.56 | -1.7% | 142.1K |
 ABCL | AbCellera Biologics Inc. Common Shares | $3.7b | $11.55 | +0.3% | 1.1M |
 OGN | Organon & Co. | $3.6b | $13.68 | +0.1% | 346.4K |
 SLS | SELLAS Life Sciences Group, Inc. Common Stock | $2.8b | $11.55 | +2.8% | 1.7M |
 NRIX | Nurix Therapeutics, Inc. Common stock | $2.6b | $25.25 | +1.3% | 215.0K |
 TRVI | Trevi Therapeutics, Inc. Common Stock | $2.4b | $15.15 | +0.4% | 624.2K |
 KOD | Kodiak Sciences Inc Common Stock | $2.4b | $32.23 | -2.5% | 176.5K |
 DAWN | Day One Biopharmaceuticals, Inc. Common Stock | $2.2b | $21.52 | -0.0% | 3.0M |
 ZYME | Zymeworks Inc. | $2.1b | $26.11 | +0.1% | 87.9K |
 GENB | Generate Biomedicines, Inc. Common Stock | $2.1b | $16.16 | -0.1% | 267.3K |
 ALVO | Alvotech Ordinary Shares | $1.9b | $5.41 | +7.3% | 1.4M |
 RXRX | Recursion Pharmaceuticals, Inc. Class A Common Stock | $1.8b | $3.27 | +0.9% | 3.2M |
 INBX | Inhibrx Biosciences, Inc. Common Stock | $1.8b | $103.67 | -1.7% | 69.5K |
 FTRE | Fortrea Holdings Inc. Common Stock | $1.7b | $20.29 | +3.0% | 500.6K |
 BCAX | Bicara Therapeutics Inc. Common Stock | $1.6b | $22.73 | +0.7% | 124.3K |
 SDGR | Schrodinger, Inc. Common Stock | $1.5b | $24.15 | +1.1% | 660.9K |
 ABSI | Absci Corporation Common Stock | $1.5b | $8.13 | +1.5% | 639.5K |
 TYRA | Tyra Biosciences, Inc. Common Stock | $1.5b | $25.22 | +0.5% | 277.5K |
 HROW | Harrow, Inc. Common Stock | $1.5b | $34.34 | +1.6% | 106.5K |
 VOR | Vor Biopharma Inc. Common Stock | $1.4b | $22.17 | -0.2% | 232.5K |
 CERT | Certara, Inc. Common Stock | $1.3b | $8.24 | -2.2% | 426.8K |
 GLUE | Monte Rosa Therapeutics, Inc. Common Stock | $1.2b | $12.74 | -1.5% | 373.1K |
 OPK | Opko Health Inc. | $1.2b | $1.63 | +2.9% | 655.5K |
 SANA | Sana Biotechnology, Inc. Common Stock | $1.2b | $3.15 | +0.2% | 513.8K |
 MRVI | Maravai LifeSciences Holdings, Inc. Class A Common Stock | $1.1b | $6.92 | +0.4% | 519.5K |
 PCRX | Pacira BioSciences, Inc. Common Stock | $1.1b | $24.45 | +1.7% | 77.4K |
 CADL | Candel Therapeutics, Inc. Common Stock | $1.0b | $11.18 | -0.1% | 331.5K |